The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Nivolumab (NIVO) + low-dose ipilimumab (IPI) as first-line (1L) therapy in microsatellite instability-high/mismatch repair-deficient (MSI-H/dMMR) metastatic colorectal cancer (mCRC): Two-year clinical update.
 
Heinz-Josef Lenz
Honoraria - Bayer; Boehringer Ingelheim; GlaxoSmithKline; Isofol Medical; Merck Serono; Roche
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; GlaxoSmithKline; Merck Serono; Roche
Travel, Accommodations, Expenses - Bayer; Merck Serono
 
Sara Lonardi
Consulting or Advisory Role - Amgen; Lilly; Merck Serono; SERVIER
Speakers' Bureau - Bristol-Myers Squibb; Lilly; Merck Serono; Roche; Servier
Research Funding - Amgen; Merck Serono
 
Vittorina Zagonel
Consulting or Advisory Role - Bristol-Myers Squibb; Merck
Speakers' Bureau - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Lilly; Roche; SERVIER
Travel, Accommodations, Expenses - Bayer; Roche; SERVIER
 
Eric Van Cutsem
Consulting or Advisory Role - Array BioPharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Celgene; Halozyme; Lilly; Merck KGaA; Merck Sharp & Dohme; Novartis; Roche; SERVIER
Research Funding - amgen (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Ipsen (Inst); Lilly (Inst); Merck (Inst); Merck KGaA (Inst); Novartis (Inst); Roche (Inst); SERVIER (Inst)
 
M. Luisa Limon
No Relationships to Disclose
 
Mark Wong
Consulting or Advisory Role - Baxalta
Speakers' Bureau - Sirtex Medical
Travel, Accommodations, Expenses - MSD Oncology
 
Alain Hendlisz
Research Funding - Amgen; Roche; Sanofi; Teva
Travel, Accommodations, Expenses - Merck Serono; Roche
 
Massimo Aglietta
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Merck; Novartis
Research Funding - AstraZeneca; PharmaMar
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Merck; Tesaro
 
Pilar Garcia-Alfonso
Consulting or Advisory Role - Amgen; Merck Serono; Roche; Sanofi; SERVIER
Speakers' Bureau - Amgen; Merck Serono; Roche; Sanofi; SERVIER
Travel, Accommodations, Expenses - Merck Serono; Roche
 
Bart Neyns
Honoraria - Bristol-Myers Squibb; Merck Sharp & Dohme; Novartis; Roche
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Merck Sharp & Dohme; Novartis; Pfizer/EMD Serono; Roche; Sanofi
Speakers' Bureau - Novartis
Research Funding - Merck KGaA (Inst); Novartis (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Merck Sharp & Dohme; Novartis; Roche
 
Fabio Gelsomino
No Relationships to Disclose
 
Dana Backlund Cardin
Consulting or Advisory Role - Abbvie; Rafael Pharmaceuticals
Research Funding - Advaxis (Inst); Array BioPharma (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); EMD Serono (Inst); Incyte (Inst); Lilly (Inst); Synta (Inst)
Travel, Accommodations, Expenses - Abbvie
 
Tomislav Dragovich
Employment - Taiho Pharmaceutical (I)
Research Funding - ARMO BioSciences; Berg Pharma; Bristol-Myers Squibb (Inst); Halozyme (Inst); Kyowa Hakko Kirin; Medivir; Rgenix
 
Usman Shah
No Relationships to Disclose
 
Jing Yang
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Jean-Marie Ledeine
Employment - Bristol-Myers Squibb
Stock and Other Ownership Interests - Bristol-Myers Squibb
 
Michael J. Overman
Consulting or Advisory Role - Array BioPharma; Bristol-Myers Squibb; Gritstone Bio; MedImmune; Novartis; Promega; Roche/Genentech; Spectrum Pharmaceuticals
Research Funding - Bristol-Myers Squibb; MedImmune; Merck; Roche